Advertisement
MO BIO
MO BIO

The Scientist

» clinical trials and ecology

Most Recent

image: Mixed Report for Oiled Salt Marshes

Mixed Report for Oiled Salt Marshes

By | June 25, 2012

Louisiana’s salt marshes are recovering from the Deepwater Horizon oil spill, but some areas have been irreversibly lost.

3 Comments

image: The Gigapixel Camera

The Gigapixel Camera

By | June 22, 2012

A single camera unit can capture a moment in time at a mind-boggling resolution.

1 Comment

image: “Extinct” Toad Rediscovered

“Extinct” Toad Rediscovered

By | June 21, 2012

A yellow-bellied dwarf toad, last sighted in 1876, is rediscovered in Sri Lanka.

0 Comments

image: A Plea to the FDA

A Plea to the FDA

By | June 21, 2012

Protesters crash the BIO conference to protest the delayed approval of a breast cancer drug.

2 Comments

image: Opinion: On the Up and Up

Opinion: On the Up and Up

By | June 20, 2012

An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.

5 Comments

image: West Coast Marine Threat

West Coast Marine Threat

By | June 18, 2012

Rising ocean acidity along the California coast may wreak havoc in the region’s oyster populations.

0 Comments

image: The Ecology of Fear

The Ecology of Fear

By | June 15, 2012

Grasshoppers in fear of predation die with less nitrogen in their bodies than unstressed grasshoppers, which can affect soil ecology.

2 Comments

image: A Greener Arctic

A Greener Arctic

By | June 11, 2012

Algal blooms are appearing under the ice in the Arctic Ocean in areas thought to receive too little light to support photosynthetic life.

0 Comments

image: Discovering Phasmids

Discovering Phasmids

By | June 9, 2012

Shortly after a rat infested supply ship ran around in Lord Howe Island off the east coast of Australia in 1918, the newly introduced mammals wiped out the island's phasmids—stick insects the size of a human hand. 

0 Comments

image: Parkinson's Vax Enters Clinical Trials

Parkinson's Vax Enters Clinical Trials

By | June 7, 2012

Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.

0 Comments

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

  3. Biologist Resigns Amid Sexual Misconduct Probe
  4. Turning Tumor Cells Against Cancer
Advertisement
Advertisement
Life Technologies